1685P Is cancer what determines COVID-19 oncological patient’s outcome or are other external factors involved? Experience in a hospital in Madrid, Spain

Abstract

Background: After COVID-19 was declared a pandemic by the World Health Organization, a response from the Italian Health System to react to an unprecedented condition became necessary and sudden. COVID-19 pandemic required oncologists to redefine clinical organization and management of cancer patients. The aim of our study was to take a picture of the situation of Italian oncologies and to evaluate the difficulties in patients management. abstracts Annals of OncologyVolume 31 -Issue S4 -2020 S997

Identification of the effects of COVID-19 on patients with pulmonary fibrosis and lung cancer: a bioinformatics analysis and literature review

“…Patients with cancer appear to be particularly vulnerable to COVID-19, as tumors can severely affect the immunological response to viral infection 4 . Delays in screening, diagnosis and treatment due to the COVID-19 pandemic could lead to excess cancer deaths and delay or even reverse projected mortality declines for some cancers 5 ; i.e., cancer patients with COVID-19 have a significantly higher mortality rate than infected patients without cancer 6 . As a result, patients with underlying diseases such as pulmonary fibrosis and lung cancer are more likely to suffer serious complications or even death after SARS-CoV-2 infection.…”